Regenxbio RGNX
NASDAQ RGNX
$7.53 +0.08 (+1.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Minority Interest (2014)

Updated

Regenxbio's Minority Interest was $12.59 million in Q4 2014.

Analysis

Regenxbio (RGNX) Minority Interest (2014) Analysis & Trends

  • In earlier years, Minority Interest was $23.56 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Regenxbio 407.85 Mn -525.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 12.59 Mn
API Access

Regenxbio Minority Interest API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=minority-interest&ticker=RGNX&period=max&api_key=YOUR_API_KEY